US Patent Issued to Gen2 Neuroscience on Jan. 20 for "Antibodies against tau epitopes" (British Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,864, issued on Jan. 20, was assigned to Gen2 Neuroscience Ltd. (Manchester, Great Britain).

"Antibodies against tau epitopes" was invented by Frederick John Livesey (Manchester, Great Britain) and Clare Jones (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to isolated synthetic or recombinant peptides comprising an epitope of human tau 2N4R, wherein the tau peptide sequence comprising the epitope is not phosphorylated. The invention also relates to use of such peptides to generate binding molecules, such as antibodies, specific for the non-phosphorylated tau epitopes and to such peptides and binding mol...